A new retrospective study of patients with high-risk t(8;21) acute myeloid leukemia (AML) investigated outcomes from 2 therapies following return of minimal residual disease–positive status after ...
Intratumoral heterogeneity as a predictive biomarker in immunotherapy for advanced non-small cell lung cancer. This is an ASCO Meeting Abstract from the 2022 ASCO Annual Meeting I. This abstract does ...
In a recent study published in The Journal of Infectious Diseases, researchers assess the proportion of interferon (IFN) autoantibodies in long-coronavirus disease (COVID) patients. Study: Low ...
When our body fights an infection, the immune system must quickly activate defenses and trigger a beneficial inflammatory response. It’s just as important to be able to resolve that inflammation and ...
The following represents disclosure information provided by the author of this manuscript. All relationships are considered compensated unless otherwise noted. Relationships are self-held unless noted ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results